Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

• Autor(es): Hegg, Roberto
• Data: 2019
• Origem: Oasisbr
• Assunto(s): ANTINEOPLÁSICOS
• Tipo de Documento: Artigo científico
• Idioma: Inglês